Article thumbnail

Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression

By Heather M. Coleman, Viv Connor, Zara S. C. Cheng, Finn Grey, Chris M. Preston and Stacey Efstathiou

Abstract

In the current study, it was shown that repressed virus genomes in quiescently infected MRC5 cells adopt a repressed histone-associated structure marked by the enrichment of deacetylated histones at a wide variety of herpes simplex virus type 1 (HSV-1) promoters. In addition, it was shown that genome de-repression, mediated by HSV-2 superinfection or delivery of ICP0 using a recombinant adenovirus vector, resulted in the enrichment of acetylated histones on HSV DNA. These data indicate that ICP0-mediated genome de-repression is intimately linked to enrichment of acetylated histones at virus promoters. The fold change in association of pan-acetylated histone H3 following Ad.TRE.ICP0-mediated de-repression consistently revealed promoter-specific variation, with the highest fold changes (>50-fold) being observed at the latency-associated transcript promoter and enhancer regions. Chromatin immunoprecipitation analyses using an antibody specific to the C terminus of histone H3 as a surrogate measure of nucleosome occupancy revealed little variability in the total loading of histone H3 at the various HSV promoters. This observation suggests that acetylation of histone H3 in response to ICP0 expression is not uniformly targeted across the HSV-1 genome during ICP0-mediated de-repression

Topics: Animal
Publisher: Society for General Microbiology
OAI identifier: oai:pubmedcentral.nih.gov:2884978
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1999). Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71.
  2. (2006). Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86.
  3. (2004). Coleman and others 76 Journal of General Virology
  4. (2005). Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells.
  5. (1989). Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.
  6. (2002). Control of cytomegalovirus lytic gene expression by histone acetylation.
  7. (2006). Deacetylation of the herpes simplex virus type 1 latencyassociated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant.
  8. (2003). Developmental stage-specific epigenetic control of human b-globin gene expression is potentiated in hematopoietic progenitor cells prior to their transcriptional activation.
  9. (1989). During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure.
  10. (2001). Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.
  11. (1991). Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814.
  12. (2006). Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.
  13. (2005). Functional inaccessibility of quiescent herpes simplex virus genomes.
  14. (2004). Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.
  15. (1989). Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system.
  16. (2001). Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
  17. (2005). Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.
  18. (1992). Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65.
  19. (2002). Histone methylation in transcriptional control.
  20. (2001). ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
  21. (2000). ICP0, a regulator of herpes simplex virus during lytic and latent infection.
  22. (1989). Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
  23. (1986). Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.
  24. (2005). Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers.
  25. other authors (2005). Genome-wide map of nucleosome acetylation and methylation in yeast.
  26. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins.
  27. (2006). Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.
  28. (2001). Quantification of human cells in NOD/ SCID mice by duplex real-time polymerase-chain reaction.
  29. (1995). Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants.
  30. (1990). Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products.
  31. (1997). Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.
  32. (2000). Repression of viral transcription during herpes simplex virus latency.
  33. (2004). Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.
  34. (2001). Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.
  35. (2004). Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.
  36. (2004). The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.
  37. (2005). Towards an understanding of the molecular basis of herpes simplex virus latency.
  38. (2001). Translating the histone code.
  39. (2004). VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection.